Lori Sakoda to Prostatic Neoplasms
This is a "connection" page, showing publications Lori Sakoda has written about Prostatic Neoplasms.
Connection Strength
1.238
-
Turning of COGS moves forward findings for hormonally mediated cancers. Nat Genet. 2013 Apr; 45(4):345-8.
Score: 0.363
-
A Large-Scale Association Study Detects Novel Rare Variants, Risk Genes, Functional Elements, and Polygenic Architecture of Prostate Cancer Susceptibility. Cancer Res. 2021 04 01; 81(7):1695-1703.
Score: 0.155
-
Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer. Nat Commun. 2017 01 31; 8:14248.
Score: 0.118
-
A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences. Cancer Discov. 2015 Aug; 5(8):878-91.
Score: 0.105
-
Imputation of the rare HOXB13 G84E mutation and cancer risk in a large population-based cohort. PLoS Genet. 2015 Jan; 11(1):e1004930.
Score: 0.103
-
Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO study. Br J Cancer. 2012 Jun 26; 107(1):207-14.
Score: 0.086
-
TNF polymorphisms and prostate cancer risk. Prostate. 2008 Mar 01; 68(4):400-7.
Score: 0.064
-
Polymorphic variants in PTGS2 and prostate cancer risk: results from two large nested case-control studies. Carcinogenesis. 2008 Mar; 29(3):568-72.
Score: 0.063
-
MSR1 variants and the risks of prostate cancer and benign prostatic hyperplasia: a population-based study in China. Carcinogenesis. 2007 Dec; 28(12):2530-6.
Score: 0.062
-
Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr. 2007 09; 86(3):s843-57.
Score: 0.062
-
Rising prostate cancer rates in South Korea. Prostate. 2006 Sep 01; 66(12):1285-91.
Score: 0.058